
### [NCIT:C7764](http://purl.obolibrary.org/obo/NCIT_C7764)
**Label:** Atypical Lymphoproliferative Disorder

**Subclasses:** [NCIT:C131906](http://purl.obolibrary.org/obo/NCIT_C131906) (EBV-Positive Mucocutaneous Ulcer), [NCIT:C115200](http://purl.obolibrary.org/obo/NCIT_C115200) (Localized Angiofollicular Lymphoid Hyperplasia), [NCIT:C3056](http://purl.obolibrary.org/obo/NCIT_C3056) (Angiofollicular Lymphoid Hyperplasia), [NCIT:C27853](http://purl.obolibrary.org/obo/NCIT_C27853) (Angiofollicular Lymphoid Hyperplasia, Hyaline-Vascular Type), [NCIT:C27854](http://purl.obolibrary.org/obo/NCIT_C27854) (Angiofollicular Lymphoid Hyperplasia, Plasma Cell Type), 

**Class expressions from DL-Learner:**

- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 60.00%
- [NCIT:C38439](http://purl.obolibrary.org/obo/NCIT_C38439) (Mature Lymphocyte) 60.00%
- [NCIT:C37165](http://purl.obolibrary.org/obo/NCIT_C37165) (Atypical Lymphocyte) 60.00%
- Thing 52.27%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 43.77%
- [CL:0000542](http://purl.obolibrary.org/obo/CL_0000542) (lymphocyte) 30.31%
- [CL:0002242](http://purl.obolibrary.org/obo/CL_0002242) (nucleate cell) 30.21%
- [CL:0000219](http://purl.obolibrary.org/obo/CL_0000219) (motile cell) 29.13%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 25.66%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 25.41%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 25.21%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 25.20%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 25.09%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 25.03%
- [CL:0000236](http://purl.obolibrary.org/obo/CL_0000236) (B cell) 20.91%


